Globus Medical reports Q3 EPS 83c, consensus 65c

Reports Q3 revenue $625.71M, consensus $603.93M. “Our third quarter results reflect the enduring strength of our business. We’ve continued to deliver on our business objectives to drive sales growth, launch new products, and execute our integration plans, all while delivering strong financial results,” said Dan Scavilla, president and CEO. “We strive to move with a sense of urgency to deliver innovations that improve the quality of life of patients with musculoskeletal disorders.”